Abstract 1787: ImmTACs: Bi-functional reagents for redirected tumour cell killing

Samantha Paston(Immunocore (United Kingdom)), Bent K. Jakobsen(Mission Therapeutics (United Kingdom)), Andrew K. Sewell(Cardiff University), Carl H. June(University of Pennsylvania), Nikolai M. Lissin(Immunocore (United Kingdom)), Annelise Vuidepot(Immunocore (United Kingdom)), Katherine J. Adams(Immunocore (United Kingdom)), Daniel Williams(Immunocore (United Kingdom)), Michael Kalos(Pillar College), Rebecca Dennis(Immunocore (United Kingdom)), Kristin Ladell(Cardiff University), Nick Pumphrey(Immunocore (United Kingdom)), Emma Gostick(University Hospital of Wales), Peter Molloy(AXON Neuroscience (Slovakia)), Giovanna Bossi(Immunocore (United Kingdom)), Andrew M. Johnson(Orthox (United Kingdom)), Frayne Bianchi(Immunocore (United Kingdom)), Brian Cameron(Immunocore (United Kingdom)), Nathaniel Liddy(Immunocore (United Kingdom)), Jessie Gavarret(Immunocore (United Kingdom)), Yi Li(Shanghai University of Traditional Chinese Medicine), David A. Price(University Hospital of Wales), Tara Mahon(Immunocore (United Kingdom)), Namir J. Hassan(Immunocore (United Kingdom)), Emma Baston(Immunocore (United Kingdom)), Anna Lissina(At Bristol), Malkit Sami(Immunocore (United Kingdom)), Jane Harper(Immunocore (United Kingdom)), Rebecca Ashfield(Immunocore (United Kingdom)), Penio Todorov(Immunocore (United Kingdom)), Emmet McCormack(Haukeland University Hospital)
Cancer Research
April 1, 2011
Cited by 0


Related Papers